Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in GLUT1 Deficiency Syndrome
NCT02014883Phase 2Completed
- Sponsor
- Inserm
- Start
- Dec 2013
- Primary completion
- Jul 2019
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triheptanoin in Glucose transporter type 1 deficiency syndrome (GLUT1DS), sponsored by Inserm. Started Dec 2013; status: completed.
02
Drugs
triheptanoin
03
Conditions
Glucose transporter type 1 deficiency syndrome (GLUT1DS)
Beyond the preview
Go deeper on NCT02014883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014883.